Navigation Links
Halozyme Therapeutics to Present at Upcoming Investor Conferences
Date:9/10/2008

SAN DIEGO, Sept. 10 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced that it will present at two investor conferences in September:

-- Merriman Curhan Ford's 5th Annual Investor Summit to be held at the Mark Hopkins InterContinental Hotel in San Francisco on Monday, September 15, 2008 at 9:30 a.m. Pacific Time (12:30 p.m. Eastern Time); and

-- UBS's 2008 Global Life Sciences Conference to be held at the Grand Hyatt Hotel in New York on Tuesday, September 23, 2008 at 2:30 p.m. Eastern Time (11:30 a.m. Pacific Time).

Interested parties can access a live audio webcast and accompanying slides of the conference presentations via the internet by visiting the Investor Relations section of Halozyme's website at http://www.halozyme.com. Archived presentations will be available on the website for 30 days following the presentation date.

About Halozyme Therapeutics, Inc.

Halozyme is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the drug delivery, metabolism, oncology, and dermatology markets. The company's portfolio of products and product candidates is based on intellectual property covering the family of human enzymes known as hyaluronidases. The company's Enhanze(TM) Technology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply Enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biolog
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives
2. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
3. Halozyme Therapeutics to Present at the Jefferies 2nd Annual Healthcare Conference
4. Halozyme Therapeutics Reports 2008 First Quarter Financial Results
5. Halozyme Therapeutics to Hold Pipeline Update Conference Call on May 9
6. Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results
7. Halozyme Therapeutics Presents Favorable New Safety and Pharmacokinetic Data on rHuPH20 Enzyme Produced Via New Manufacturing Process at European Federation for Pharmaceutical Sciences
8. Halozyme Therapeutics to Hold Pipeline Update Conference Call on March 14
9. Halozyme Therapeutics to Present at the BIO CEO and Investor Conference and the Roth Growth Stock Conference
10. Halozyme Therapeutics Amends Stockholder Rights Plan
11. Halozyme Therapeutics Reports 2007 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... SAN DIEGO , July 28, 2014 ... algae cultivation technologies, today announced the appointment of biotechnology ... member of the board of directors. Levine replaces Cynthia ... effective immediately. She will remain chairman of the company,s ... leadership on Sapphire Energy,s mission to deliver commercial scale ...
(Date:7/28/2014)... Reston, VA (PRWEB) July 28, 2014 ... leading nonprofit authority on the use of health IT ... its Health Plan Identifier (HPID) Workgroup has ... Between a Health Plan and Payer?” The HPID Workgroup, ... worked closely with the Centers for Medicare and Medicaid ...
(Date:7/28/2014)... Texas (PRWEB) July 28, 2014 ... and China Lubricant Industry” is a professional ... Global Lubricant market. The report introduces Lubricant ... and industry chain structure and industry overview. ... including China’s domestic market as well as ...
(Date:7/28/2014)... 2014 According to a new ... "Regenerative Medicine (Bone and Joint) Market (By Technology ... By Applications - Bone Graft Substitutes, Osteoarticular Diseases, ... Industry Analysis, Size, Share, Growth, Trends and Forecast, ... and joint) market was valued at USD 2.6 ...
Breaking Biology Technology:Sapphire Energy Announces New CEO James Levine 2Sapphire Energy Announces New CEO James Levine 3WEDI’s HPID Workgroup Announces Release of Issue Brief: “What is the Difference Between a Health Plan and Payer?” 2Lubricant Market & Adhesion Promoter Industry (Globa, China) Analysis Now Available at DeepResearchReports.com 2Lubricant Market & Adhesion Promoter Industry (Globa, China) Analysis Now Available at DeepResearchReports.com 3Lubricant Market & Adhesion Promoter Industry (Globa, China) Analysis Now Available at DeepResearchReports.com 4Regenerative Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 2Regenerative Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 3Regenerative Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 4
... for faster and better business analysis, reporting and decision-making , ... ... ( www.visual-io.com ) today announced and unveiled the newest generation ... intelligence at the IBM Cognos Forum ( http://www.cognos.com/cognosforum/ ), taking place ...
... Partnering Strategy and Process for Picoplatin -SOUTH SAN FRANCISCO, ... PARD ), a biopharmaceutical company focused on innovative ... chief operating officer, will present at the BIO International ... Time in Atlanta. Mr. Martell will provide an ...
... 12 Masimo Corporation (Nasdaq: MASI ), the ... oximetry, today announced that its management is scheduled to present ... Boston, Massachusetts, on Tuesday, May 19, 2009, at 2:35 p.m. ... available on the Masimo website at www.masimo.com . ...
Cached Biology Technology:Visual i/o Combines Advanced Dynamic Visual Business Intelligence and Search Through New Software 2Visual i/o Combines Advanced Dynamic Visual Business Intelligence and Search Through New Software 3Visual i/o Combines Advanced Dynamic Visual Business Intelligence and Search Through New Software 4Poniard Pharmaceuticals to Present at the 2009 BIO International Convention 2Poniard Pharmaceuticals to Present at the 2009 BIO International Convention 3Masimo to Present at the Deutsche Bank 34th Annual Health Care Conference 2
(Date:7/27/2014)... A new in vitro study has revealed that nicotine ... DNA damage caused by a certain carcinogen in smoke. ... the curing of tobacco leaves and ultimately ends up ... in the lung and liver, where it is activated ... Previous research in mice has revealed that nicotine can ...
(Date:7/27/2014)... -- Microorganisms like bacteria and fungi can evade treatment ... or antifungal drugs. These permanent mutations were once thought ... evolve. Now a new study has shown that microorganisms ... known as epimutations -- to gain the benefits of ... mechanism was discovered in a fungus called Mucor circinelloides, ...
(Date:7/27/2014)... scientists have identified more than two dozen genetic ... that had not been previously reported. The study, ... funded by the National Institutes of Health (NIH) ... , "Unraveling the genetic underpinnings of Parkinson,s is ... this complex disease, and hopefully, may one day ...
Breaking Biology News(10 mins):Nicotine found to inhibit DNA-strand break caused by a certain carcinogen in smoke 2Scientists discover new, noncommittal mechanism of drug resistance 2Scientists discover new, noncommittal mechanism of drug resistance 3NIH scientists find 6 new genetic risk factors for Parkinson's 2
... researchers at the University of Illinois published a discovery that ... discovery which was based on an analysis of ribosomal ... cells opened up a new field of study, and ... To mark the anniversary of this discovery, the university ...
... Research Charity --Presents 2007 Prizes ,for Outstanding Psychiatric Research ... Prize winners have significantly contributed to the knowledge ... disorders NEW YORK, N.Y., Oct. 16, 2007Five of ... presented to scientists of great achievement by NARSAD, the ...
... after an American was hanged in London in one of ... forensic science at Michigan State University is producing evidence that ... hanged for murdering and dismembering his showgirl wife, then fleeing ... in hot pursuit. Loaded with enough sordid details and twists ...
Cached Biology News:Symposium marks 30th anniversary of discovery of third domain of life 2Symposium marks 30th anniversary of discovery of third domain of life 3Symposium marks 30th anniversary of discovery of third domain of life 4NARSAD presents 2007 prizes for outstanding achievement in neuroscience and psychiatric research 2NARSAD presents 2007 prizes for outstanding achievement in neuroscience and psychiatric research 3NARSAD presents 2007 prizes for outstanding achievement in neuroscience and psychiatric research 4NARSAD presents 2007 prizes for outstanding achievement in neuroscience and psychiatric research 5Science casts doubt on famous British murder case 2Science casts doubt on famous British murder case 3
Monkey IL-2 ELISPOT Kit with white/opague microtiter plates...
B2-Microgloulin...
...
... EVO series offers versatile liquid handling platforms ... a wide variety of life science applications.The ... base sizes (75, 100, 150 and 200 ... a platform that will advance with their ...
Biology Products: